Common use of Service Monitoring Clause in Contracts

Service Monitoring. 10.1 Performance monitoring will be in line with service standards and the pharmacy may be monitored on the following: Availability of appropriate material to support the provision of advice to the client group. Maintenance of accurate records as required by the PGD. Reviews of standard operating procedures and updates as necessary. Participation in the bi-annual review of service provision including any updated developments. The outcomes of any patient experience surveys, feedback or complaints. The proportion of the number of women under 25 who received EHC and have been given a Chlamydia screening pack. The proportion of Chlamydia screening packs that is returned to the screening service from women under 25. A review of the number of occasions when an accredited pharmacist was not available to provide the services at the pharmacy. 10.2 Information outlining the process of the service must be cascaded to other pharmacy staff. 10.3 Non-pharmacist staff must be trained to refer clients to an accredited pharmacist. Where an accredited pharmacist is unavailable on the premises, clients should be signposted to an appropriate alternative service. 10.4 Non-pharmacists may not be accredited nor are they allowed, by law, to supply via this patient group direction (PGD). Pharmacies should inform the CCC as soon as possible in situations where an accredited pharmacist will no longer be available to provide the service. 10.5 Pharmacies should inform the CCC as soon as possible in situations where the designated pharmacy signatory is no longer able to retain responsibility for the SLA operating in a given accredited pharmacy, to enable transfer of designated signatory status or termination of the agreement.

Service Monitoring. 10.1 Performance monitoring will be in line with service standards and the pharmacy may be monitored on the following:  Availability of appropriate material to support the provision of advice to the client group.  Maintenance of accurate records as required by the PGD.  Reviews of standard operating procedures and updates as necessary.  Participation in the bi-annual review of service provision including any updated developments.  The outcomes of any patient experience surveys, feedback or complaints.  The proportion of the number of women under 25 who received EHC and have been given a Chlamydia screening pack.  The proportion of Chlamydia screening packs that is returned to the screening service from women under 25.  A review of the number of occasions when an accredited pharmacist was not available to provide the services at the pharmacy. 10.2 Information outlining the process of the service must be cascaded to other pharmacy staff. 10.3 Non-pharmacist staff must be trained to refer clients to an accredited pharmacist. Where an accredited pharmacist is unavailable on the premises, clients should be signposted to an appropriate alternative service. 10.4 Non-pharmacists may not be accredited nor are they allowed, by law, to supply via this patient group direction (PGD). Pharmacies should inform the CCC as soon as possible in situations where an accredited pharmacist will no longer be available to provide the service. 10.5 Pharmacies should inform the CCC as soon as possible in situations where the designated pharmacy signatory is no longer able to retain responsibility for the SLA operating in a given accredited pharmacy, to enable transfer of designated signatory status or termination of the agreement.